A study on the efficacy of recombinant human endostatin combined with apatinib mesylate in patients with middle and advanced stage non-small cell lung cancer.
Year: 2019
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Authors: Jian Zhao, Haibing Yu, Tianci Han, Wei Wang, Wei Tong, Xiangyu Zhu
Institution: China Medical University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3006156536